Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 4693-4704 of 5143
Hansa Biopharma Interim Report January-September 2023
Edwards MITRIS RESILIA Valve Receives CE Mark for Mitral Replacement Surgeries
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses
Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
New data from LEQEMBI® (lecanemab-irmb) phase 3 Clarity AD study and subcutaneous formulation presented at CTAD
Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023
Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe
Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
Prev
Page
1
2
…
391
392
393
…
428
429
Next
Page
